Generation of hydroxyl radicals by the antiviral compound phosphonoformic acid (foscarnet)

Pharmacology and Toxicology

Volumn 89, Issue 1, 2001, Pages 49-55

  Lindqvist, Christer ^a   Nordström, Tommy ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; COUMARIN 3 CARBOXYLIC ACID; COUMARIN DERIVATIVE; DIMETHYL SULFOXIDE; FERRIC ION; FERROUS ION; FERROZINE; FOSCARNET; GLUCOSE; HYDROXYL RADICAL; MANNITOL; PEROXIDE; PHOSPHATE; SCAVENGER; SINGLE STRANDED DNA; SUCROSE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CHELATION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA NICK TRANSLATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

CYTOMEGALOVIRUS; DNA VIRUSES; LETHRINIDAE;

EID: 0034913873     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2001.d01-135.x     Document Type: Article

References (33)

1. Baker, M. & J. M. Gebicki: The effect of pH on yields of hydroxyl radicals produced from superoxide by potential biological iron chelators. Arch. Biochem. Biophys. 1986, 246, 581-588.
2. Bhuyan, K. C. & D. K. Bhuyan: Superoxide dismutase of the eye: relative functions of superoxide dismutase and catalase in protecting the ocular lens from oxidative damage. Biochim. Biophys. Acta. 1978, 542, 28-38.
3. Biaglow, J. E. & A. V. Kachur: The generation of hydroxyl radicals in the reaction of molecular oxygen with polyphosphate complexes of ferrous ion. Radiation Res. 1997, 148, 181-187.
4. Celander, D. W. & T. R. Cech: Iron(II)-ethylenediaminetetraacetic acid catalyzed cleavage of RNA and DNA oligonucleotides: Similar reactivity towards single- and double-stranded forms. Biochemistry 1990, 29, 1355-1361.
5. Cheung, T. W. & S. A. Teich: Cytomegalovirus infection in patients with HIV infection. Mt. Sinai J. Med. 1999, 66, 113-124.
6. Chrisp, P. & S. P. Clissold: Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991, 41, 104-129.
7. Crumpacker, C. S.: Mechanism of action of Foscarnet against viral polymerases. Amer. J. Med 1992, 92 Suppl. 2A: 3S-7S.
8. Das, B. N., D. V. Weinberg & L. M. Jampol: Cytomegalovirus retinitis. Brit. J. Hosp. Med. 1994, 52, 163-166.
9. Datta, A. K. & R. E. Hood: Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid. Virology 1981, 114, 52-59.
10. Eriksson, B., B. Öberg & B. Wahren: Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Biochim. Biophys. Acta 1982, 696, 115-123.
11. Eriksson, B., A. Larsson, E. Helgstrand, N.-G. Johansson & B. Oberg: Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Biochim. Biophys. Acta 1980, 607, 53-64.
12. Feinstein, E., E. Canaani & L. M. Weiner: Dependence of nucleic acid degradation on in situ free-radical production by adriamycin. Biochemistry 1993, 32, 13156-13161.
13. Fletcher, C. V., A. C. Collier, F. S. Rhame, D. Bennett, M. F. Para, C. C. Beatty, C. E. Jones & H. H. Balfour Jr: Foscarnet for suppression of human immunodeficiency virus replication. Antimicrob. Agents Chemother. 1984, 38, 604-607.
14. Geladopoulos, T. P., T. G. Sotiroudis & A. E. Evangelopoulos: A malachite green colorimetric assay for protein phosphatase activity. Anal. Biochem. 1991, 192, 112-116.
15. Halliwell, B. & J. M. Gutteridge: Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch. Biochem. Biophys. 1986, 246, 501-514.
16. Halliwell, B. & J. M. Gutteridge: Role of free radicals and catalytic metal ions in human disease. Meth. Enzymol. 1990, 186, 1-85.
17. Helgstrand, E., B. Eriksson, N. G. Johansson, B. Lannerö, A. Larsson, A. Misiorny, J. O. Noren, B. Sjöberg, K. Stenberg, G. Stening, S. Stridh & B. Öberg: Trisodium phosphonoformate, a new antiviral compound. Science 1978, 201, 819-821.
18. Herzberg, R. P. & P. B. Dervan: Cleavage of DNA with methidium-propyl-EDTA-iron (II): Reaction conditions and product analyses. Biochemistry 1984, 23, 3934-3945.
19. Jacobson, M. A., S. Crowe, J. Levy, F. Aweeka, J. Gambertoglio, N. McManus & J. Mills: Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. J. Infect. Dis. 1988, 158, 862-865.
20. Kazakov, S. A., T. G. Astashkina S. V. Mamaev & V. V. Vlassov: Site-specific cleavage of single-stranded DNAs at unique sites by a copper-dependent redox reaction. Nature 1988, 335, 186-188.
21. Lam, K. W., J. Zwaan, A. Garcia & C. Shields: Detection of ascorbic acid in the eye of the early chicken embryo by silver staining. Exp. Eye Res. 1993, 56, 601-604.
22. Manevich, Y., K. D. Held & J. E. Biaglow: Coumarin-3-carboxylic acid as a detector for hydroxyl radicals generated chemically and by gamma radiation. Radiat. Res. 1997, 148, 580-591.
23. Repine, J. E., O. W. Pfenninger, D. W. Talmage, E. M. Berger & D. E. Pettijohn: Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl and radical. Proc. Natl. Acad. Sci. 1981, 78, 1001-1003.
24. Sandström, E. G., R. E. Byington, J. C. Kaplan & M. S. Hirsch: Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate. Lancet 1985, 1, 1480-1482.
25. Sarin, P. S., Y. Taguchi, D. Sun, A. Thornton, R. C. Gallo & B. Öberg: Inhibition of HTLV-III/LAV replication by foscarnet. Biochem. Pharmacol. 1985, 34, 4075-4079.
26. Sigman, D. S.: Chemical nucleases. Biochemistry 1990, 29, 9097-9105.
27. Sundquist B. & B. Öberg: Phosphonoformate inhibits reverse transcriptase. J. Gen. Virol. 1979, 45, 273-281.
28. Tso, M. O., B. J. Woodford & K. W. Lam: Distribution of ascorbate in normal primate retina and after photic injury: a biochemical, morphological correlated study. Exp. Eye Res. 1984, 3, 181-191.
29. Wagstaff, A. J. & H. M. Bryson: Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 1994, 48, 199-226.
30. Vile, F. G., C. C. Winterbourn & H. C. Sutton: Radical-driven Fenton reactions: Studies with paraquat, adriamycin and anthraquinone 6-sulfonate and citrate, ATP, ADP, and pyrophosphate iron chelates. Arch. Biochem. Biophys. 1987, 259, 616-626.
31. Vrang, L. & B. Öberg: PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob. Agents Chemother. 1986, 29, 867-872.
32. Yamashita, H., K. Horie, T. Yamamoto, H. Katagiri, T. Asano, T. Hirano, T. Nagano & Y Oka: Superoxide dismutase in developing mouse retina. Jap. J. Ophthalmol. 1994, 38, 148-161.
33. Öberg, B.: Molecular basis of foscarnet action. In: Human herpesvirus infections. Eds.: Carlos Lopez and Bernard Roizman. Raven Press, New York, 1986, 141-151.